fingolimod hydrochloride has been researched along with Kidney Diseases in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bradley, MJ; Clark, N; Davis, TA; Elster, EA; Foster, AD; Leonhardt, C; Vicente, D | 1 |
| Dam, W; Hijmans, RS; Navis, G; Poosti, F; van den Born, J; van Goor, H; Yazdani, S | 1 |
| Awad, AS; Bajwa, A; Jo, SK; Kharel, Y; Lynch, KR; Okusa, MD; Vergis, AL; Ye, H | 1 |
| Binder, E; Budde, K; Khadzhynov, D; Krämer, S; Loof, T; Martini, S; Neumayer, HH; Peters, H; Wang-Rosenke, Y | 1 |
| Xie, M; Zhou, JH | 1 |
| David, OJ; Kovarik, JM; Schmouder, RL | 1 |
| Burne, MJ; Garcia, JG; Hassoun, PM; McVerry, BJ; Pearse, D; Peng, X; Rabb, H; Sammani, S; Tuder, RM | 1 |
| Ahn, KO; Bang, BK; Choi, BS; Kim, J; Kim, JS; Kim, JY; Kim, YS; Li, C; Lim, SW; Yang, CW; Yang, HJ | 1 |
| Harada, T; Kanekake, H; Nishikido, M | 1 |
| Illana Esteban, C | 1 |
3 review(s) available for fingolimod hydrochloride and Kidney Diseases
| Article | Year |
|---|---|
Clinical pharmacokinetics of fingolimod.
Topics: Animals; Blood Proteins; Drug Interactions; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Kidney Diseases; Liver Diseases; Multiple Sclerosis; Propylene Glycols; Protein Binding; Sphingosine | 2012 |
[Molecular action mechanisms of the therapeutic agents for kidney diseases: Immunosuppressants].
Topics: Antibodies, Monoclonal; Azathioprine; Basiliximab; Cyclophosphamide; Cyclosporine; Fatty Acids, Monounsaturated; Fingolimod Hydrochloride; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Mycophenolic Acid; Propylene Glycols; Recombinant Fusion Proteins; Ribonucleosides; Sphingosine | 2006 |
[Cordyceps sinensis, a fungi used in the Chinese traditional medicine].
Topics: Animals; Cordyceps; Cyclosporine; Didanosine; Drug Costs; Drugs, Chinese Herbal; Fingolimod Hydrochloride; History, 19th Century; History, 20th Century; History, Ancient; Humans; Kidney Diseases; Larva; Medicine, Chinese Traditional; Moths; Mycology; Oxygen Consumption; Propylene Glycols; Sphingosine | 2007 |
7 other study(ies) available for fingolimod hydrochloride and Kidney Diseases
| Article | Year |
|---|---|
FTY720 Effects on Inflammation and Liver Damage in a Rat Model of Renal Ischemia-Reperfusion Injury.
Topics: Animals; Disease Models, Animal; Fingolimod Hydrochloride; Inflammation; Kidney; Kidney Diseases; Liver; Male; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Transcription Factor AP-1 | 2019 |
Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats.
Topics: Animals; Antibodies; Biomarkers; Clodronic Acid; Collagen Type III; Disease Models, Animal; Doxorubicin; Fibrosis; Fingolimod Hydrochloride; Inflammation; Kidney Diseases; Kidney Tubules; Leukocyte Count; Liposomes; Lymphangiogenesis; Lymphatic Vessels; Macrophages; Male; Myofibroblasts; Proteinuria; Rats, Wistar; RNA, Messenger; T-Lymphocytes; Vascular Endothelial Growth Factor Receptor-3 | 2015 |
Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury.
Topics: Animals; Fingolimod Hydrochloride; Gene Expression Regulation, Enzymologic; Kidney; Kidney Diseases; Lysophospholipids; Mice; Mice, Knockout; Phosphotransferases (Alcohol Group Acceptor); Propylene Glycols; Reperfusion Injury; RNA, Messenger; Sphingosine | 2009 |
The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
Topics: Animals; Blood Pressure; Cell Movement; Cell Proliferation; Disease Models, Animal; Extracellular Matrix; Fibrosis; Fingolimod Hydrochloride; Hypertension; Immunosuppressive Agents; Kidney; Kidney Diseases; Lymphocytes; Macrophages; Male; Nephrectomy; Propylene Glycols; Proteinuria; Rats; Rats, Wistar; Sphingosine; Transforming Growth Factor beta | 2009 |
[FTY720 reduces peritubular micrangium loss in renal interstitial fibrotic rats].
Topics: Animals; Apoptosis; Capillaries; Fibrosis; Fingolimod Hydrochloride; Kidney Diseases; Kidney Tubules; Male; Propylene Glycols; Rats; Rats, Sprague-Dawley; Sphingosine; Vascular Diseases | 2009 |
Protective effects of sphingosine 1-phosphate in murine endotoxin-induced inflammatory lung injury.
Topics: Animals; Bronchoalveolar Lavage Fluid; Capillary Permeability; Disease Models, Animal; Endothelial Cells; Endotoxins; Fingolimod Hydrochloride; Immunosuppressive Agents; Kidney; Kidney Diseases; Lipopolysaccharides; Lung; Lysophospholipids; Male; Mice; Mice, Inbred C57BL; Neutrophils; Organ Size; Perfusion; Peroxidase; Pneumonia; Propylene Glycols; Respiratory Distress Syndrome; Sphingosine; Time Factors | 2004 |
Effect of FTY720 on chronic cyclosporine nephropathy in rats.
Topics: Angiotensin II; Animals; Chronic Disease; Cyclosporine; Extracellular Matrix Proteins; Fibrosis; Fingolimod Hydrochloride; Immunosuppressive Agents; Kidney; Kidney Diseases; Lymphocytes; Macrophages; Male; Osteopontin; Propylene Glycols; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Sphingosine; T-Lymphocytes; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |